ENKTL
Showing 26 - 30 of 30
Lymphoma, Extranodal NK-T-Cell Trial in GuangZhou (Gemcitabine, Oxaliplatin, Pegaspargase)
Terminated
- Lymphoma, Extranodal NK-T-Cell
- Gemcitabine
- +8 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 8, 2018
Lymphoma, Extranodal NK-T-Cell Trial in Guangzhou (GELOX, IFRT)
Unknown status
- Lymphoma, Extranodal NK-T-Cell
- GELOX
- IFRT
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center; State Key Laboratory of On
Apr 18, 2016
Lymphoma,, Non-Hodgkin Lymphoma,, Extranodal NK/T-cell Lymphoma,Nasal-type, Trial in Guangzhou (Mild-dose IMRT)
Unknown status
- Lymphoma,
- +2 more
- Mild-dose IMRT
-
Guangzhou, Guangdong, ChinaDept. Radiation Oncology, Sun Yat-sen University Cancer Center
Sep 28, 2014
Lymphoma, Extranodal NK-T-Cell Trial in Xi'an (MESA chemo, MESA)
Unknown status
- Lymphoma, Extranodal NK-T-Cell
- MESA chemotherapy
- MESA
-
Xi'an, Shaanxi, ChinaDepartment of Hemaology, Xi jing Hospital,The Fourth Military Me
Dec 21, 2013
Histologically Proven Extranodal NKTcell Lymphoma Trial in Korea, Republic of (Romidepsin)
Completed
- Histologically Proven Extranodal NKTcell Lymphoma
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +3 more
Jul 29, 2013